From owner-freebsd-virtualization@freebsd.org Thu Mar 17 13:31:06 2016 Return-Path: Delivered-To: freebsd-virtualization@mailman.ysv.freebsd.org Received: from mx1.freebsd.org (mx1.freebsd.org [IPv6:2001:1900:2254:206a::19:1]) by mailman.ysv.freebsd.org (Postfix) with ESMTP id 92222AD3A3D for ; Thu, 17 Mar 2016 13:31:06 +0000 (UTC) (envelope-from bouncer@me22564.mailengine1.com) Received: from me22564.mailengine1.com (me22564.mailengine1.com [72.19.229.130]) by mx1.freebsd.org (Postfix) with ESMTP id 40D36F71 for ; Thu, 17 Mar 2016 13:30:44 +0000 (UTC) (envelope-from bouncer@me22564.mailengine1.com) Received: by me22564.mailengine1.com (PowerMTA(TM) v3.5r14) id htaoo80j0pkg for ; Thu, 17 Mar 2016 05:43:03 -0700 (envelope-from ) MIME-Version: 1.0 X-Mailer: StreamSend2 - 351669 X-Mailer-Version: 2.0 X-Mailer-Environment: production X-Report-Abuse-At: abuse@streamsend.com X-Report-Abuse-Info: It is important to please include full email headers in the report X-rpcampaign: StreamSend26268375 X-Streamsend2id: 351669+1+8392467+26268375+me22564.mailengine1.com Date: Thu, 17 Mar 2016 05:41:31 -0700 From: "European Prefilled Syringes Summit, London" Reply-To: "Mohammad Ahsan" To: freebsd-virtualization@freebsd.org Subject: =?iso-8859-1?Q?New=20Speakers=20Announced=20-=20Register=20Now?= =?iso-8859-1?Q?=20to=20Save=20=A3300=20on=20Early=20Bird=20Discount?= Message-ID: <100.0.2.B6.1D1804A8C06D81A.DCC1E@me22564.mailengine1.com> Content-Type: text/plain; charset=utf-8 Content-Transfer-Encoding: quoted-printable X-Content-Filtered-By: Mailman/MimeDel 2.1.21 X-BeenThere: freebsd-virtualization@freebsd.org X-Mailman-Version: 2.1.21 Precedence: list List-Id: "Discussion of various virtualization techniques FreeBSD supports." List-Unsubscribe: , List-Archive: List-Post: List-Help: List-Subscribe: , X-List-Received-Date: Thu, 17 Mar 2016 13:31:06 -0000 European Prefilled Syringes Summit Reshaping the next generation of injectable drug delivery Register By 8th April 2016 to Take Advantage of The 20% Early Bird Discount Discounted Price: =C2=A31195 (ex.VAT) Standard Price: =C2=A31,495 (ex.VAT). To confirm your participation Contact: Mohammad Ahsan on +44 (0) 203 141 0606 or email: mahsan@acieu.net Join ACI=E2=80=99s European Prefilled Syringes Summit taking place in Londo= n, UK, on the 7th =E2=80=93 8th=20 September, 2016 and hear from Florence Schwarzenbach, Senior Clinical Development Manager, Becton Dickin= son (BD) Thomas Fischer, Senior Quality Manager Medical Device, Novartis Hadj Latreche, Combination Products (Medical Device & Drug) Methods, Proces= s and Infrastructure Group Leader, Roche Pharmaceuticals Mike Hrytsak, Manager, Combination Products Regulatory Affairs, Regeneron P= harmaceuticals Ramesh Kumar, Senior Scientist, MedImmune Ian Thompson, Vice President Business Development, Ypsomed AG=20 Fabien Roy, Senior Associate, Hogan Lovells Martin Murphy, Marketing Lead MedTech Division, CambridgeConsultants=20 Andy Varde, Director of Research & Development, Owen Mumford=20 Join us in London to exchange your point of view with your peers and engage= in excellent networking opportunities. For more information, Contact: Mohammad Ahsan on +44 (0) 203 141 0606 or email: mahsan@acieu.net Early Confirmed Speakers Include: Thomas Fischer, Senior Quality Manager Medical Device, Novartis Hadj Latreche, Combination Products (Medical Device & Drug) Methods, Proces= s and Infrastructure Group Leader, Roche Pharmaceuticals Ian Thompson, Vice President Business Development, Ypsomed AG Fabien Roy, Senior Associate, Hogan Lovells Martin Murphy, Marketing Lead MedTech Division, Cambridge Consultants=20 Andy Varde, Director of Research & Development, Owen Mumford Key Topics Include: - What issues decide the future of the industry and market - Incorporating human factor engineering into a patient-centric device - Ensure commercial competitiveness of PFS as a drug device - Assess trends of combination products and impacts on PFS - Best practices for the challenging molecular properties: Smart packaging = solutions for highly sensitive compounds - Injectable drug selection criteria - Rethinking approaches to formulation alongside integrating it into manufa= cturing operations - Learn about the latest cutting edge technological developments to acceler= ate your PFS development - Hear from Cambridge Consultants on next generation design devices includi= ng platforms, pumps and featured functionality that works for value chain - Improving cost control through manufacturing in customisable disposable d= evices - Developing strategies to de-risk its supply chain logistics - Next generation smart devices showcase: demonstrating usability and techn= ology advances - Prospects for applications in prefilled technology =E2=80=93 anticipating= requirements for the future Who Will Attend? Senior management within: Head of Device Development Head of Global Product Management Head of Human Factors Senior Application Specialists Senior Packaging Engineers Manager, Finished Products and Medical Devices Head of Device and Delivery Injectables Senior Director, Packaging Head of Medical Devices and Finished Products Register By 8th April 2016 to Take Advantage of The 20% Early Bird Discount null Discounted Price: =C2=A31195 (ex.VAT) Standard Price: =C2=A31,495 (ex.VAT). To confirm your participation Contact: Mohammad Ahsan on +44 (0) 203 141 0606 or email: mahsan@acieu.net Active Communications Europe Ltd. www.wplgroup.com | mahsan@acieu.net Sales and Support: +44 (0) 203-141-0606 -- 5/13 Great Suffolk Str. London, SE1 0NS United Kingdom -- http://app.streamsend.com/private/Cwfm/y2j/qwmd1lL/unsubscribe/26= 268375=